Our previous studies have shown that murine tumor cells sensitive to natural killer (NK) or natural cytotoxic (NC) cellmediated lysis have to capacity to specifically bind laminin in a time and concentration dependent manner while tumor cells resistant to NK/NC killing bind much less laminin. Furthermore, we have shown that NK cells express a structure on their surface which is immunochemically cross reactive with laminin. These finding suggest that laminin and laminin receptors may provide a mechanism by which natural cellmediated cytotoxic cells recognize potential targets. The observation that the addition of exogenous laminin to NK or NC killing assays inhibits tumor cell lysis by preventing NK/NC target binding supports this hypothesis. The overall goal of this research proposal is to precisely define the role of laminin and laminin receptors in murine NK and NC killing of tumor cells.
Two specific aims will be carried out. The first will focus on the NK and NC effector cells. We will use flow cytometry to compare the binding of affinity purified and monoclonal antilaminin antibodies with the binding of antibodies to known NK markers by populations of murine spleen cells. Both single color and two color fluorescence will be done. (We will also use antilaminin antibodies in the presence or absence of complement in an attempt to modulate NK and NC binding to target cells and NKand NCmediated killing of these cells). Finally, we will use immunochemical and biochemic approaches to purify and characterize the laminin-like antigens on the NK/NC cell surface. In the second specific aim we will focus on the potential target cells. We will characterized the laminin binding capacity and sensitivity to NK- or NC-mediated killing of several murine tumor cell lines. We will attempt to isolate from these populations, cells lines with liminin-binding capacity relative to that of the parent populations. The variant lines will then be determine whether laminin/laminin receptors on NK susceptible tumor cells contribute to their sensitivity to lysis by NK cell derived cytolytic factors (NKCF) and whether such cytolytic factors are immunochemically crossreactive with laminin. We hope that these studies will provide definitive evidence for the role of laminin and laminin receptors in the recognition and killing of murine tumor cells by natural cell mediated effector cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA043765-02
Application #
3186097
Study Section
Experimental Immunology Study Section (EI)
Project Start
1987-01-01
Project End
1989-12-31
Budget Start
1988-01-01
Budget End
1988-12-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
Overall Medical
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Hiserodt, J C (1993) Lymphokine-activated killer cells: biology and relevance to disease. Cancer Invest 11:420-39
Jamieson, G A; Agrawal, A K; Greco, N J et al. (1992) Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline. Biochem J 285 ( Pt 1):35-9
Schwarz, R E; Vujanovic, N L; Hiserodt, J C (1989) Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Cancer Res 49:1441-6
Sarneva, M; Vujanovic, N L; Van den Brink, M R et al. (1989) Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells. Cell Immunol 118:448-57
Chambers, W H; Vujanovic, N L; DeLeo, A B et al. (1989) Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med 169:1373-89
Vujanovic, N L; Herberman, R B; Hiserodt, J C (1988) Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity. Cancer Res 48:878-83
Vujanovic, N L; Herberman, R B; Maghazachi, A A et al. (1988) Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells. J Exp Med 167:15-29
Schwarz, R E; Hiserodt, J C (1988) The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes. J Immunol 141:3318-23
Vujanovic, N L; Herberman, R B; Olszowy, M W et al. (1988) Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells. Cancer Res 48:884-90
Maghazachi, A A; Vujanovic, N L; Herberman, R B et al. (1988) Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells. J Immunol 140:2846-52

Showing the most recent 10 out of 11 publications